Cargando…
Ancient genes can be served as pan‐cancer diagnostic and prognostic biomarkers
One important challenge for cancer is efficient biomarkers monitoring its formation and developments remain greatly limited. Although the accumulated big omics data provide great opportunities to the above purpose, the biomarkers identified by the data‐driven strategy often do not work well in new d...
Autores principales: | Ji, Xiangwen, Cui, Qinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299709/ https://www.ncbi.nlm.nih.gov/pubmed/32368859 http://dx.doi.org/10.1111/jcmm.15347 |
Ejemplares similares
-
ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019) -
SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
por: Li, Zihua, et al.
Publicado: (2022) -
A Panel of Synapse-Related Genes as a Biomarker for Gliomas
por: Ji, Xiangwen, et al.
Publicado: (2020) -
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
por: Chen, Dengwang, et al.
Publicado: (2023) -
GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival
por: Yang, Dingquan, et al.
Publicado: (2020)